Mechanisms of action of NME metastasis suppressors - a family affair. [PDF]
Cancer Metastasis Rev, 2023 Prunier C, Chavrier P, Boissan M.
europepmc +1 more source
Metastasis suppressor genes in clinical practice: are they druggable? [PDF]
Cancer Metastasis Rev, 2023 Gelman IH.
europepmc +1 more source
NME2 modulates HCC progression through 4EBP1 phosphorylation and autophagy regulation independent of mTOR. [PDF]
Hepatol CommunChen W +9 more
europepmc +1 more source
Bioinformatics and experimental approaches identify NME8 as a promoter of the metastasis of renal cell carcinoma by activating the JAK/STAT signaling pathway. [PDF]
Clin Exp MedMa Y, Yang L, Zhan F.
europepmc +1 more source
Emerging Molecular Connections between NM23 Proteins, Telomeres and Telomere-Associated Factors: Implications in Cancer Metastasis and Ageing. [PDF]
Int J Mol Sci, 2021 Sharma S, Sengupta A, Chowdhury S.
europepmc +1 more source
Comprehensive Phenotypic and Proteomic Analyses of Human Reticulocyte Maturation. [PDF]
Blood Red Cells IronLeduc M +9 more
europepmc +1 more source
Correlation Between Onco-suppressors PTEN and NM23 and Clinical Outcome in Patients With T1 Breast Cancer. [PDF]
In Vivo, 2021 Izzo L +6 more
europepmc +1 more source
Unraveling resistance mechanisms to the novel nucleoside analog RX-3117 in lung cancer: insights into DNA repair, cell cycle dysregulation and targeting PKMYT1 for improved therapy. [PDF]
J Exp Clin Cancer ResVahabi M +13 more
europepmc +1 more source
Targeting NME3 to Restore Mitochondrial Fission-Fusion Balance Defines a Novel Disease-Modifying Strategy for Parkinson's Disease. [PDF]
CNS Neurosci TherQiao C +5 more
europepmc +1 more source
BRG1: Promoter or Suppressor of Cancer? The Outcome of BRG1's Interaction with Specific Cellular Pathways. [PDF]
Int J Mol Sci, 2023 Shaykevich A +3 more
europepmc +1 more source